Smithfield Trust’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.9M | Sell |
5,934
-2,035
| -26% | -$1.1M | 0.13% | 93 |
|
|
2025
Q4 | $4.62M | Buy |
7,969
+1,869
| +31% | +$1.06M | 0.2% | 71 |
|
|
2025
Q3 | $2.96M | Buy |
6,100
+140
| +2% | +$65.2K | 0.13% | 89 |
|
|
2025
Q2 | $2.41M | Sell |
5,960
-13
| -0.2% | -$5.43K | 0.11% | 95 |
|
|
2025
Q1 | $2.95M | Sell |
5,973
-318
| -5% | -$172K | 0.15% | 82 |
|
|
2024
Q4 | $3.27M | Buy |
6,291
+243
| +4% | +$134K | 0.16% | 83 |
|
|
2024
Q3 | $3.73M | Buy |
6,048
+96
| +2% | +$56.8K | 0.18% | 80 |
|
|
2024
Q2 | $3.29M | Sell |
5,952
-2
| -0% | -$1.15K | 0.17% | 73 |
|
|
2024
Q1 | $3.47M | Sell |
5,954
-40
| -0.7% | -$22.4K | 0.18% | 75 |
|
|
2023
Q4 | $3.18M | Sell |
5,994
-415
| -6% | -$201K | 0.18% | 78 |
|
|
2023
Q3 | $3.26M | Buy |
6,409
+408
| +7% | +$217K | 0.2% | 73 |
|
|
2023
Q2 | $3.13M | Buy |
6,001
+132
| +2% | +$71.2K | 0.19% | 75 |
|
|
2023
Q1 | $3.39M | Sell |
5,869
-348
| -6% | -$196K | 0.22% | 64 |
|
|
2022
Q4 | $3.43M | Buy |
6,217
+129
| +2% | +$68.4K | 0.23% | 68 |
|
|
2022
Q3 | $3.1M | Buy |
6,088
+22
| +0.4% | +$12.3K | 0.22% | 65 |
|
|
2022
Q2 | $3.29M | Buy |
6,066
+91
| +2% | +$50.1K | 0.23% | 60 |
|
|
2022
Q1 | $3.54M | Buy |
5,975
+489
| +9% | +$281K | 0.23% | 63 |
|
|
2021
Q4 | $3.66M | Buy |
5,486
+249
| +5% | +$155K | 0.23% | 66 |
|
|
2021
Q3 | $3M | Sell |
5,237
-203
| -4% | -$111K | 0.2% | 70 |
|
|
2021
Q2 | $2.75M | Sell |
5,440
-88
| -2% | -$41.5K | 0.18% | 78 |
|
|
2021
Q1 | $2.52M | Sell |
5,528
-484
| -8% | -$231K | 0.17% | 75 |
|
|
2020
Q4 | $2.8M | Sell |
6,012
-600
| -9% | -$281K | 0.2% | 71 |
|
|
2020
Q3 | $2.92M | Buy |
6,612
+39
| +0.6% | +$16.1K | 0.24% | 67 |
|
|
2020
Q2 | $2.38M | Sell |
6,573
-117
| -2% | -$39.2K | 0.21% | 72 |
|
|
2020
Q1 | $1.9M | Sell |
6,690
-411
| -6% | -$130K | 0.2% | 72 |
|
|
2019
Q4 | $2.31M | Sell |
7,101
-155
| -2% | -$47K | 0.21% | 75 |
|
|
2019
Q3 | $2.11M | Buy |
7,256
+288
| +4% | +$82.5K | 0.21% | 74 |
|
|
2019
Q2 | $2.05M | Buy |
6,968
+630
| +10% | +$174K | 0.21% | 69 |
|
|
2019
Q1 | $1.74M | Sell |
6,338
-103
| -2% | -$25.6K | 0.19% | 75 |
|
|
2018
Q4 | $1.44M | Sell |
6,441
-145
| -2% | -$34K | 0.17% | 79 |
|
|
2018
Q3 | $1.61M | Sell |
6,586
-110
| -2% | -$25.3K | 0.17% | 82 |
|
|
2018
Q2 | $1.39M | Buy |
6,696
+9
| +0.1% | +$1.91K | 0.16% | 83 |
|
|
2018
Q1 | $1.38M | Sell |
6,687
-38
| -0.6% | -$7.98K | 0.17% | 82 |
|
|
2017
Q4 | $1.28M | Buy |
6,725
+377
| +6% | +$72.2K | 0.16% | 91 |
|
|
2017
Q3 | $1.2M | Buy |
6,348
+885
| +16% | +$160K | 0.16% | 87 |
|
|
2017
Q2 | $953K | Hold |
5,463
| – | – | 0.14% | 98 |
|
|
2017
Q1 | $839K | Sell |
5,463
-95
| -2% | -$14.5K | 0.13% | 102 |
|
|
2016
Q4 | $784K | Sell |
5,558
-51
| -0.9% | -$7.52K | 0.13% | 106 |
|
|
2016
Q3 | $892K | Sell |
5,609
-49
| -0.9% | -$7.55K | 0.16% | 83 |
|
|
2016
Q2 | $836K | Buy |
5,658
+29
| +0.5% | +$4.28K | 0.16% | 92 |
|
|
2016
Q1 | $797K | Buy |
5,629
+475
| +9% | +$63.7K | 0.16% | 92 |
|
|
2015
Q4 | $731K | Buy |
5,154
+84
| +2% | +$11.2K | 0.15% | 96 |
|
|
2015
Q3 | $620K | Buy |
5,070
+120
| +2% | +$15.6K | 0.13% | 117 |
|
|
2015
Q2 | $643K | Sell |
4,950
-50
| -1% | -$6.52K | 0.13% | 118 |
|
|
2015
Q1 | $672K | Buy |
5,000
+4,400
| +733% | +$567K | 0.13% | 119 |
|
|
2014
Q4 | $75K | Hold |
600
| – | – | 0.02% | 450 |
|
|
2014
Q3 | $73K | Hold |
600
| – | – | 0.01% | 460 |
|
|
2014
Q2 | $71K | Hold |
600
| – | – | 0.01% | 490 |
|
|
2014
Q1 | $72K | Hold |
600
| – | – | 0.01% | 484 |
|
|
2013
Q4 | $67K | Hold |
600
| – | – | 0.01% | 476 |
|
|
2013
Q3 | $55K | Hold |
600
| – | – | 0.01% | 484 |
|
|
2013
Q2 | $51K | Buy |
+600
| New | +$49.9K | 0.01% | 475 |
|
Other funds holding TMO
VCM
Smithfield Trust's TMO Position: Q1 2026 in Review
Smithfield Trust reduced its Thermo Fisher Scientific (TMO) stake by 26% in Q1 2026, selling an estimated $1.1M and leaving 5,934 shares worth $2.9M. The position accounts for 0.13% of the portfolio, ranked #93.
Smithfield Trust first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.62M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Smithfield Trust held 5,934 shares of Thermo Fisher Scientific worth $2.9M as of Q1 2026.
- Smithfield Trust sold 2,035 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.1M.
- Thermo Fisher Scientific made up 0.13% of Smithfield Trust's portfolio in Q1 2026, its #93 holding.
- Smithfield Trust first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Smithfield Trust's Thermo Fisher Scientific position peaked at $4.62M in Q4 2025.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.